Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonidegib in locally advanced basal cell carcinoma in China
NCT06880848Phase 4Completed
- Sponsor
- Jemincare
- Start
- Jun 2023
- Primary completion
- Aug 2025
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of sonidegib in basal cell carcinoma (BCC), sponsored by Jemincare. Started Jun 2023; status: completed.
02
Drugs
sonidegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT06880848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06880848.